company background image
PPLPHARMA logo

Piramal Pharma NSEI:PPLPHARMA Stock Report

Last Price

₹245.90

Market Cap

₹332.2b

7D

-4.9%

1Y

98.1%

Updated

21 Nov, 2024

Data

Company Financials +

Piramal Pharma Limited

NSEI:PPLPHARMA Stock Report

Market Cap: ₹332.2b

PPLPHARMA Stock Overview

Operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. More details

PPLPHARMA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health2/6
Dividends0/6

Rewards

Earnings are forecast to grow 77.72% per year

Became profitable this year

Risk Analysis

Interest payments are not well covered by earnings

Volatile share price over the past 3 months compared to the Indian market


Piramal Pharma Limited Competitors

Ajanta Pharma

NSEI:AJANTPHARM

₹366.4b

Suven Pharmaceuticals

NSEI:SUVENPHAR

₹325.7b

Ipca Laboratories

NSEI:IPCALAB

₹399.5b

Gland Pharma

NSEI:GLAND

₹293.8b

Price History & Performance

Summary of all time highs, changes and price drops for Piramal Pharma
Historical stock prices
Current Share Price₹245.90
52 Week High₹307.90
52 Week Low₹114.35
Beta0.084
11 Month Change14.31%
3 Month Change31.79%
1 Year Change98.15%
33 Year Changen/a
5 Year Changen/a
Change since IPO29.42%

Recent News & Updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Recent updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Jul 14
Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Jun 17
Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

May 21
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Mar 26
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Feb 28
Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Feb 02
Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Nov 09
Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Aug 11
Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Shareholder Returns

PPLPHARMAIN PharmaceuticalsIN Market
7D-4.9%-0.2%0.3%
1Y98.1%40.5%27.3%

Return vs Industry: PPLPHARMA exceeded the Indian Pharmaceuticals industry which returned 40.5% over the past year.

Return vs Market: PPLPHARMA exceeded the Indian Market which returned 27.3% over the past year.

Price Volatility

Is PPLPHARMA's price volatile compared to industry and market?
PPLPHARMA volatility
PPLPHARMA Average Weekly Movement8.8%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

Stable Share Price: PPLPHARMA's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: PPLPHARMA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
20206,719n/awww.piramalpharma.com

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene and protection.

Piramal Pharma Limited Fundamentals Summary

How do Piramal Pharma's earnings and revenue compare to its market cap?
PPLPHARMA fundamental statistics
Market cap₹332.23b
Earnings (TTM)₹453.30m
Revenue (TTM)₹87.04b

719.2x

P/E Ratio

3.7x

P/S Ratio

Is PPLPHARMA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PPLPHARMA income statement (TTM)
Revenue₹87.04b
Cost of Revenue₹34.68b
Gross Profit₹52.36b
Other Expenses₹51.90b
Earnings₹453.30m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.34
Gross Margin60.15%
Net Profit Margin0.52%
Debt/Equity Ratio58.7%

How did PPLPHARMA perform over the long term?

See historical performance and comparison

Dividends

0.04%

Current Dividend Yield

79%

Payout Ratio